Certain alleles at two SNP sites in TP53 coincided with decreased colorectal cancer risk or an earlier time of disease onset in a study of almost 300 Taiwanese individuals with Lynch syndrome.
By studying variants in PCSK9, researchers reported the therapies targeting the gene would have some of the same effects as statins.
One group pointed out differences between study group characteristics, while the other wondered about the role of patient preference.
University of Cambridge researchers found that people who learned their genetic risk of developing diabetes did not have increased motivation to make lifestyle changes.
The new assay, called the CellMax-DNA Genetic Cancer Risk Test, will complement CellMax Life's planned slate of liquid biopsy assays for early cancer detection.
Using CNV profiles for more than 40,000 individuals with or without schizophrenia, researchers got a refined look at gains and losses linked to the condition.
An international team of researchers examined genetic and lifestyle factors linked to heart disease in some 55,600 people.
In Science this week: researchers call for balance in the use of gene-editing tools, and more.
Using exome sequence and phenotyping data for individuals from longitudinal population studies, investigators began parsing pathogenic mutation effects in the genes.
Using mitochondrial sequence data for hundreds of simplex families, investigators found predicted pathogenic heteroplasmic mutations were over-represented.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.